Zobrazeno 1 - 10
of 103
pro vyhledávání: '"Maria Koltowska-Häggström"'
Autor:
Ilonka Kreitschmann-Andermahr, Sonja Siegel, Christa Gammel, Karen Campbell, Leslie Edwin, Agnieszka Grzywotz, Victoria Kuhna, Maria Koltowska-Häggström, Oliver Müller, Michael Buchfelder, Bernadette Kleist
Publikováno v:
International Journal of Endocrinology, Vol 2018 (2018)
Background. Cushing’s disease (CD) and Cushing’s syndrome (CS) are chronic illnesses, characterized by symptoms of prolonged hypercortisolism, which often changes to hypocortisolism after successful treatment. In view of the high disease burden o
Externí odkaz:
https://doaj.org/article/055fa52dbf4046a696ef0419d9190e51
Publikováno v:
Dermatologic Surgery. 46:145-147
Autor:
Maria Koltowska-Häggström, Márta Korbonits, Andy Toogood, Peter Jonsson, Ann-Charlotte Åkerblad, Helena Gleeson, M. Tanya Mitra, Peter E. Clayton
Publikováno v:
Mitra, M T, Jönsson, P J, Akerbald, A-C, Clayton, P, Koltowska-Häggström, M, Korbonits, M, Toogood, A & Gleeson, H 2017, ' Social, Educational, and Vocational Outcomes in Patients with Childhood Onset and Young Adult Onset Growth Hormone Deficiency ', Clinical Endocrinology . https://doi.org/10.1111/cen.13291
Objective Hypopituitarism diagnosed in childhood, adolescence and young adulthood has the potential to affect growth and somatic development. Less is known about the impact of such a diagnosis on other aspects of development. Design An analysis of th
Autor:
Cecilia Camacho-Hübner, Thierry Brue, Judith Hey-Hadavi, Roy Gomez, Christian J. Strasburger, Aart Jan van der Lely, Michael Droste, Maria Koltowska-Häggström, Ann Charlotte Akerblad, Anders Lindberg
Publikováno v:
Endocrine, 63(3), 563-572. Humana Press
Endocrine
Endocrine, Springer, 2019, 63 (3), pp.563-572. ⟨10.1007/s12020-018-1792-0⟩
Endocrine
Endocrine, Springer, 2019, 63 (3), pp.563-572. ⟨10.1007/s12020-018-1792-0⟩
PurposeTo explore the effects of pegvisomant (PEGV) on glucose metabolism in patients with acromegaly within ACROSTUDY, an international, observational, prospective safety surveillance study.MethodsPatients were retrospectively divided into two cohor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eaddc38fc3d2ce9368f9d1c6ae42c1be
https://pure.eur.nl/en/publications/b4289a7a-3c8e-4af3-a2ca-9bb3582d433e
https://pure.eur.nl/en/publications/b4289a7a-3c8e-4af3-a2ca-9bb3582d433e
Autor:
Oliver Müller, Sonja Siegel, Tsambika Psaras, Monika Milian, Dagmar Führer, Maria Koltowska-Häggström, Bernadette Kleist, Michael Buchfelder, Christa Menzel, Jürgen Honegger, Ulrich Sure, Ilonka Kreitschmann-Andermahr, Maria Tsiogka
Publikováno v:
Pituitary. 19:590-600
Quality of life (QoL) and psychosocial well-being are substantially impaired in patients with Cushing’s disease (CD), not only at the acute illness stage but also after therapy; however, the reason for these impairments remains unclear. In this cro
Publikováno v:
Clinical Endocrinology. 83:842-848
Objective Published data on eye disorders in patients with Turner syndrome (TS) are limited. We aimed to evaluate the prevalence of eye disorders in patients with TS and assess the association with patient karyotype. Design Cross-sectional, observati
Autor:
Maria Koltowska-Häggström, Murray B. Gordon, Pamela U. Freda, Nicky Kelepouris, Peter Jonsson, A. J. van der Lely
Publikováno v:
Endocrine Practice, 21(3), 264-274. American Association of Clinical Endocrinology
Objective: To evaluate use of pegvisomant, a growth hormone (GH) receptor antagonist, as monotherapy in ACROSTUDY, a global safety surveillance study set in 14 countries (373 sites). Methods: A descriptive analysis of safety, magnetic resonance imagi
Autor:
Ann-Charlotte Åkerblad, Helena Filipsson Nyström, Gudmundur Johannsson, Anders F Mattsson, Oskar Ragnarsson, Maria Koltowska-Häggström, John P Monson
Publikováno v:
European Journal of Endocrinology. 171:571-579
ObjectiveQuality of life (QoL) is impaired in hypopituitary patients and patients with primary adrenal insufficiency. The aim of this study was to analyse the impact of glucocorticoid (GC) replacement on QoL. The main hypothesis was that ACTH-insuffi
Autor:
David M. Cook, Susan L. Greenspan, Donna King, Maria Koltowska-Häggström, Amir H. Hamrahian, Peter Jonsson, Nicholas A. Tritos, Beverly M. K. Biller
Publikováno v:
Clinical Endocrinology. 79:178-184
SummaryObjective Growth hormone (GH) replacement may increase bone mineral density (BMD) in GH-deficient (GHD) adults. The goal of this study was to identify predictors of BMD response to GH replacement in GH naive adults. Design and measurements Thi
Autor:
Anders F. Mattsson, Miklós Góth, Johan Verhelst, Patrick Wilton, Roger Abs, Maria Koltowska-Häggström, Maria Thunander, Anton Luger
Publikováno v:
European Journal of Endocrinology. 168:297-305
ObjectiveGH deficiency (GHD) in adults is characterized by a tendency toward obesity and an adverse body composition with visceral fat deposit and may thus predispose to the development of type 2 diabetes mellitus. The aim of this study was to assess